Phase 3 Trial of ROTAVAC 5D Vaccine in Chilean Infants Underway
A phase 3 trial is evaluating the efficacy and safety of ROTAVAC 5D, a live attenuated rotavirus vaccine, in 5800 healthy infants.
Company
Pharmaceutical intelligence for Bharat Biotech with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.